Zn(II)–curcumin prevents cadmium-aggravated diabetic nephropathy by regulating gut microbiota and zinc homeostasis
Frontiers in Pharmacology · 05.06.2024 · 15
DOI: 10.3389/fphar.2024.1411230 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 05.06.2024. Verfasst von Wenjia Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Traditional Chinese Medicine and Marine Drugs, Institute of Aquatic Economic Animals and Guangdong Provincial Key Laboratory for Aquati…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Diabetic nephropathy (DN) is known as the most common complication of diabetes, resulting from a complex inheritance-environment interaction without effective clinical treatments. Herein, we revealed the protective effects and mechanisms of Zn(II)-curcumin, a curcumin derivative, against streptozotocin-induced DN in rats in the presence or absence of cadmium exposure.
Methods
The present study focused on investigating the therapy of Zn(II)-curcumin against cadmium-aggravated DN by regulating gut microbiota, metabolism, inflammation and zinc homeostasis based on pathological changes, TLR4/NF-κB signaling pathway, inductively coupled plasma-mass spectrometry (ICP-MS), 16S rRNA gene sequencing and gas chromatography-mass spectrometer (GC-MS).
Results
We found Zn(II)-curcumin significantly mitigated the cadmium-aggravated phenotypes of diabetic nephropathy, as indicated by the remission of renal dysfunction, pathological changes, inflammation and zinc dyshomeostasis in streptozotocin-treated rats exposed to cadmium. Administration of Zn(II)-curcumin significantly alleviated the dysbiosis of gut microbiota and the changes of serum metabolite profiles in rats treated with streptozotocin in combination with cadmium. Notably, fecal microbial transplantation identified the ability of Zn(II)-curcumin to regulate renal function, inflammation and zinc homeostasis was partly dependent on the gut microbiota.
Conclusion
These findings revealed that Zn(II)-curcumin alleviated cadmium-aggravated diabetic nephropathy by reshaping the gut microbiota and zinc homeostasis, which provided unique insights into the mechanisms of the treatment and prevention of diabetic nephropathy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Traditional Chinese Medicine and Marine Drugs, Institute of Aquatic Economic Animals and Guangdong Provincial Key Laboratory for Aquatic Economic Animals, School of Life Sciences, Sun Yat-sen University, G…
- Laboratory Animal Center, Sun Yat-sen University, Guangzhou, China.
Zitieren
APA
Sun, W., Mei, X., Wang, J., Mai, Z., & Xu, D. (2024). Zn(II)–curcumin prevents cadmium-aggravated diabetic nephropathy by regulating gut microbiota and zinc homeostasis. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1411230
Vancouver
Sun W, Mei X, Wang J, Mai Z, Xu D. Zn(II)–curcumin prevents cadmium-aggravated diabetic nephropathy by regulating gut microbiota and zinc homeostasis. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1411230
BibTeX
@article{Sun2024,
author = {Sun, Wenjia and Mei, Xueting and Wang, Jiasheng and Mai, Zhicong and Xu, Donghui},
title = {Zn(II)–curcumin prevents cadmium-aggravated diabetic nephropathy by regulating gut microbiota and zinc homeostasis},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1411230}
}
EUVIMED